Laura Carter
No más puestos en curso
Fortuna: 89 990 $ al 31/03/2024
Perfil
Laura Carter worked as a Scientific Director at MedImmune LLC, Director at Young Womens Christian Association USA, Senior Research Investigator at Array BioPharma, Inc., Senior Vice President-Biology at Lycera Corp., and Principal at Wyeth Research.
She also served as the Chief Scientific Officer at Gossamer Bio, Inc. from 2021 to 2023.
Dr. Carter received her undergraduate degree from Massachusetts Institute of Technology and her doctorate from UC San Diego School of Medicine.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GOSSAMER BIO, INC.
0.03% | 20/03/2023 | 76 263 ( 0.03% ) | 89 990 $ | 31/03/2024 |
Antiguos cargos conocidos de Laura Carter.
| Empresas | Cargo | Fin |
|---|---|---|
| GOSSAMER BIO, INC. | Chief Tech/Sci/R&D Officer | 15/06/2023 |
Wyeth Research
 Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The private company is based in Cambridge, MA. | Corporate Officer/Principal | - |
Lycera Corp.
 Lycera Corp. Pharmaceuticals: MajorHealth Technology Lycera Corp. develops novel oral medicines for treating autoimmune diseases and cancer. It specializes in immune metabolism, cell signaling and immune cell differentiation. The firm designed gut-directed ATPase modulator, designated LYC-30937, for the treatment of inflammatory bowel disease, and oral RORgamma agonists for diverse applications in immune-oncology. The company was founded in 2006 by Anthony William Opipari, Jr., and Gary D. Glick and is headquartered in Ann Arbor, MI. | Corporate Officer/Principal | - |
| ARRAY TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Chief Tech/Sci/R&D Officer | - |
Formación de Laura Carter.
| Massachusetts Institute of Technology | Undergraduate Degree |
| UC San Diego School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| GOSSAMER BIO, INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Lycera Corp.
Lycera Corp. Pharmaceuticals: MajorHealth Technology Lycera Corp. develops novel oral medicines for treating autoimmune diseases and cancer. It specializes in immune metabolism, cell signaling and immune cell differentiation. The firm designed gut-directed ATPase modulator, designated LYC-30937, for the treatment of inflammatory bowel disease, and oral RORgamma agonists for diverse applications in immune-oncology. The company was founded in 2006 by Anthony William Opipari, Jr., and Gary D. Glick and is headquartered in Ann Arbor, MI. | Health Technology |
Young Womens Christian Association USA
 Young Womens Christian Association USA Services to the Health IndustryHealth Services Young Womens Christian Association USA operates as a multicultural women's organization. It provides shelters, child care, employment training, job placement, and youth development programs for women. The firm also sponsors racial justice, antiviolence, and human rights advocacy programs. Young Women's Christian Association was founded in 1855 and is headquartered in Washington, DC. | Health Services |
Wyeth Research
Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The private company is based in Cambridge, MA. | Commercial Services |
- Bolsa de valores
- Insiders
- Laura Carter
